Back
Neurocrine Biosciences Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
68
NBIX
Neurocrine Biosciences
Last Price:
$139.06
Seasonality Move:
9.43%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 136.02 | Buy |
| 20-day SMA: | 130.74 | Buy |
| 50-day SMA: | 125.01 | Buy |
| 200-day SMA: | 133.09 | Buy |
| 8-day EMA: | 135.48 | Buy |
| 20-day EMA: | 131.7 | Buy |
| 50-day EMA: | 127.72 | Buy |
| 200-day EMA: | 128.46 | Buy |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.62 | Buy |
| Relative Strength Index (14 RSI): | 71.82 | Buy |
| Chaikin Money Flow: | 880074 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (125.2 - 134.3) | Buy |
| Bollinger Bands (100): | (115.21 - 138.45) | Buy |
Neurocrine Biosciences Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 139.03 while NBIX 8-day simple moving average is 136.02, which is a Buy signal.
-
The stock price of NBIX is 139.03 while Neurocrine Biosciences 20-day SMA is 130.74, which makes it a Buy.
-
Neurocrine Biosciences 50-day simple moving average is 125.01 while NBIX share price is 139.03, making it a Buy technically.
-
NBIX stock price is 139.03 and Neurocrine Biosciences 200-day simple moving average is 133.09, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
68
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a BuyThe current Neurocrine Biosciences [NBIX] share price is $139.03. The Score for NBIX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
14.1B
Price in USD:
139.03
Share Volume:
920.8K
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
110.95
Buy
68
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?The Neurocrine Biosciences stock price is 139.03 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 139.03 while NBIX 8-day exponential moving average is 135.48, which is a Buy signal.
-
The stock price of NBIX is 139.03 while Neurocrine Biosciences 20-day EMA is 131.70, which makes it a Buy.
-
Neurocrine Biosciences 50-day exponential moving average is 127.72 while NBIX share price is 139.03, making it a Buy technically.
-
NBIX stock price is 139.03 and Neurocrine Biosciences 200-day simple moving average is 128.46, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.27 per share, and an increase next year of $1.14 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is 3.62, suggesting Neurocrine Biosciences is a Buy
-
Neurocrine Biosciences Relative Strength Index (RSI) is 71.82, which suggest Neurocrine Biosciences is overbought
-
The Bollinger Bands (25) for Neurocrine Biosciences is (125.2 - 134.3), which suggest Neurocrine Biosciences is a Buy
-
The Bollinger Bands (100) for Neurocrine Biosciences is (115.21 - 138.45), which suggest Neurocrine Biosciences is a Buy
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.